FlowApps

Investigators have proven the effectiveness of using fluorescent targets in phagocytic assays instead of live infectious agents. Flow Apps enhances those methods with a multiplexed cytometric approach by:

• Detecting functional antibodies with differentially labeled fluorescent targets
• Detecting antibody panels for multiple serotypes in a single assay
• Increasing throughput using automation

+Speed and Other Benefits+

Flow Applications’ approach yields reproducible results similar to those obtained by first generation killing assays by Steiner and Nahm, but at a much higher throughput. With autoloaders, batch analysis, and curve-fitting software, multiplexing technologies deliver even faster results – while enabling vaccine researchers and developers to:

• Accelerate phagocytic assays up to 20 times while reducing serum and reagent use by up to 75%
• Eliminate biohazards and technical difficulties associated with live bacteria
• Reduce inter- and intra-laboratory variability with established performance parameters

+A Solution for Finding Answers+

Flow Applications’ solution is a process platform that includes technology, scientific knowledge, patented methods, and frameworks for best practices. Flow Applications tailors its solutions to its customers’ requirements by:

• Supporting customers with training, collateral materials, and knowledge transfer
• Providing reference laboratory services
• Providing customized assay development services
• Providing standardized reference and control reagents

Flow Applications enables pharmaceutical, bio-defense, public health, clinical, and academic research organizations to reduce the time it takes to evaluate immune response pre or post-vaccination. Flow Applications offers its customers a range of options and methodologies that promote efficiencies and cost-effectiveness.